touchREVIEWS in Respiratory & Pulmonary Diseases Volume 6, Issue 1, 2021
Welcome to our new issue of touchREVIEWS in Respiratory & Pulmonary Diseases. This free-to-access issue is full of topical content on a range of subjects, which we think will be of interest for you across the spectrum of respiratory & pulmonary medicine, including reviews around the treatment of Primary Ciliary Dyskinesia, NSAID-Exacerbated Respiratory Disease, Alpha-1 Antitrypsin Deficiency Lung Disease and much more.
We hope you’ll find something of interest in this issue, and we look forward to continuing to share new and exciting content into 2022 and beyond. Thanks to all who contributed and provided their expertise in putting together this edition, and to all of our authors, editorial board members and partners for their work this year. If you’re interested in contributing to our upcoming 2022 issues, please feel free to submit [here] or contact us directly.
Foreword touchREVIEWS in Respiratory & Pulmonary Diseases Volume 6, Issue 1, 2021
Welcome to the latest issue of touchREVIEWS in Respiratory & Pulmonary Diseases. The past three years have been intensely busy, chaotic and traumatic, especially for those of us working in the respiratory field. Having personally spent hundreds of hours only working in COVID-19-related critical care, I have missed out on many new developments in respiratory healthcare. […]
Proton Pump Inhibitors and Risk of Infection: Is Suppression of Immune Defence Molecules to Blame?
Proton pump inhibitors (PPIs) are a class of antacid drugs that are available by prescription and over-the-counter to treat gastro-oesophageal reflux disease in patients with a number of comorbidities, including chronic respiratory diseases, such as asthma, pulmonary arterial hypertension, chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.1 Although they are generally regarded as safe and effective […]
Sleep Disorders in Neuromuscular Diseases: Adaption in Care Provision During the COVID-19 Pandemic
Sleep disturbances are exceedingly common and potentially morbid in patients with neuromuscular diseases (NMD).1 A constellation of physiologic changes occur in patients with NMDs which, in concert with normal physiologic changes during sleep, lead to decreased nocturnal ventilation that often precedes daytime hypoventilation. The standard manner in which we diagnose and treat sleep disorders in this […]
European Respiratory Society Guidelines for the Management of Bronchiectasis in Children and Adolescents
Bronchiectasis is a chronic pulmonary disorder characterized by permanent bronchial dilatation, which in some children may be reversible, and airway inflammation, and by cough and sputum production, as well as recurrent respiratory tract infections.1 Bronchiectasis is associated with poor quality of life for the child/adolescent and their parents, recurrent exacerbations and high cost to healthcare systems.2 […]
Non-tuberculous Mycobacteria Infection: A Neglected Disease in Bangladesh
Despite huge strides in the fight against TB, the WHO’s Global Tuberculosis Report 2019 ranked Bangladesh sixth among the countries with the highest number of TB cases (4% of the global total), and seventh among the top 10 countries with the widest gap between notified and incident TB cases.1 Funding for TB programmes remains challenging and an obstacle […]
Recent Advances in Primary Ciliary Dyskinesia: From Diagnosis to Treatment
Primary ciliary dyskinesia (PCD), previously known as immotile cilia syndrome, is a rare genetic disease characterized by abnormal ciliary function due to defects in the structure and/or function of motile cilia, leading to recurrent and chronic infections of the upper and lower airways as a result of impaired mucociliary clearance.1 PCD is predominantly inherited in […]
Management of Non-steroidal Anti-inflammatory Drug-exacerbated Respiratory Disease
Aspirin-exacerbated respiratory disease (AERD) is a clinical triad of asthma, nasal polyposis and sensitivity to aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs). These patients have severe sinopulmonary inflammation, often refractory to standard treatments.1 However, significant advances in the management of both asthma and nasal polyposis allow for new treatment options and management algorithms. This article aims […]
Updates in the Management of Alpha-1 Antitrypsin Deficiency Lung Disease
Alpha-1 antitrypsin (AAT) deficiency (AATD) is the second most common genetic disease to cause clinically significant lung disease, surpassed only by cystic fibrosis.1 AAT is a serine protease inhibitor primarily produced in hepatocytes, with a normal plasma level of 20–53 µM or 90–200 mg/dL and a half-life of 3–5 days.2 AAT is transported via the systemic circulation […]
Blood Eosinophils in Chronic Obstructive Pulmonary Disease: Is There Enough Evidence?
The lack of well-validated biomarkers for monitoring disease activity, predicting future clinical outcomes and the effect of therapeutic interventions highlights the need to find new biomarkers in chronic obstructive pulmonary disease (COPD). In recent years, extensive research has gone into identifying and attempting to validate relevant diagnostic biomarkers of disease activity and therapeutic response.1 A […]
Nirsevimab: An Extended Half-life Monoclonal Antibody for the Prevention of Infant Respiratory Syncytial Virus Infection
Respiratory syncytial virus (RSV) is a ubiquitous virus that causes annual epidemics of infection in young children in all parts of the world. In temperate regions, epidemics are seasonal, and predictable during the winter months. Approximately half of all infants develop their first RSV infection prior to their first birthday. By 24 months of age, […]
Mepolizumab as Anti-interleukin-5 Therapy for Chronic Rhinosinusitis with Nasal Polyposis
Chronic rhinosinusitis (CRS) is a heterogeneous inflammatory disease of the nose and paranasal sinuses that is prevalent worldwide, affecting 10–12% of adults.1,2 It is phenotypically classified by the presence or absence of nasal polyps. Chronic rhinosinusitis with nasal polyposis (CRSwNP) is estimated to affect up to 4% of the population, and consists of multiple endotypes that […]
Factors Predisposing Patients to Asthma Exacerbation Requiring Hospitalization: A Retrospective Study Among Lebanese Patients
Asthma, classically defined as a chronic inflammatory disease of the lower respiratory tract, is a heterogeneous array of clinical disorders that differ in intensity, occurrence, triggers, comorbidities, genetics, clinical course and prognosis.1 It manifests as wheezing, cough, dyspnoea, chest tightness and fatigue.2 These manifestations can be episodic or permanent, and are usually associated with a variable, obstructive, […]
Journal articles and more to your inbox
Get the latest clinical insights from touchRESPIRATORYSign me up!